Improved Hypertension Control with the Imidazoline Agonist Moxonidine in a Multinational Metabolic Syndrome Population: Principal Results of the MERSY Study
This study was designed to assess the effects of moxonidine on blood pressure and aspects of the metabolic syndrome in racially diverse population of patients encountered in routine medical practice. Physicians collected data on a minimum of three consecutive patients with uncontrolled essential hyp...
Saved in:
| Main Authors: | Irina Chazova, Markus P. Schlaich |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | International Journal of Hypertension |
| Online Access: | http://dx.doi.org/10.1155/2013/541689 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
by: E. V. Tishina, et al.
Published: (2011-06-01) -
An imidazoline receptor agonist, moxonidine, in optimization of arterial hypertension treatment among postmenopausal women
by: A. B. Bakhshaliev, et al.
Published: (2006-02-01) -
Place of imidazoline receptor agonists in the treatment of arterial hypertension
by: D. V. Nebieridze, et al.
Published: (2023-12-01) -
Moxonidine for arterial hypertension treatment in menopausal women with metabolic syndrome
by: V. V. Trusov, et al.
Published: (2007-08-01) -
Personalized approach to the treatment of patients with arterial hypertension: focus on imidazoline receptor agonists. Opinion on the problem
by: E. I. Baranova, et al.
Published: (2025-03-01)